Bing‐Ching Ho
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Oncology top 10%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
Papers in
-
- Cancer Genomics and Diagnostics 5
- MicroRNA in disease regulation 4
-
- RNA regulation and disease 5
- RNA Research and Splicing 5
- Co-authors
- Sung‐Liang YuPan‐Chyr YangKang‐Yi SuGee‐Chen ChangMin‐Liang KuoKer-Chau LiJin‐Yuan ShihJames Chih‐Hsin Yang
- Journals
- Oncotarget (3 papers)PLoS ONE (3 papers)Journal of Cellular Biochemistry (2 papers)Scientific Reports (2 papers)Cellular Microbiology (2 papers)
- Partner nations
- TaiwanUnited StatesAustralia
In The Last Decade
Bing‐Ching Ho
29 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Cancer Research 420
- Oncology 352
- Pulmonary and Respiratory Medicine 409
- Molecular Biology 627
- Immunology 160
Countries citing papers authored by Bing‐Ching Ho
This map shows the geographic impact of Bing‐Ching Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing‐Ching Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing‐Ching Ho more than expected).
Fields of papers citing papers by Bing‐Ching Ho
This network shows the impact of papers produced by Bing‐Ching Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing‐Ching Ho. The network helps show where Bing‐Ching Ho may publish in the future.
Co-authors
The 25 scholars most cited alongside Bing‐Ching Ho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 11 | |
| 2 | 2021 | 5 | |
| 3 | 2020 | 5 | |
| 4 | 2019 | 17 | |
| 5 | 2019 | 15 | |
| 6 | 2018 | 10 | |
| 7 | 2017 | 26 | |
| 8 | 2016 | 24 | |
| 9 | 2016 | 20 | |
| 10 | 2016 | 14 | |
| 11 | 2016 | 2 | |
| 12 | 2016 | 39 | |
| 13 | 2015 | 75 | |
| 14 | 2015 | 11 | |
| 15 | 2014 | 120 | |
| 16 | 2013 | 45 | |
| 17 | Pretreatment Epidermal Growth Factor Receptor ( EGFR ) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer Hit paper breakdown → | 2012 | 429 |
| 18 | 2011 | 128 | |
| 19 | 2009 | 46 | |
| 20 | 2009 | 36 |
About Bing‐Ching Ho
Bing‐Ching Ho is a scholar working on Cancer Research, Molecular Biology, Oncology, Cardiology and Cardiovascular Medicine and Molecular Medicine, having authored 29 papers that have together received 1.2k indexed citations. Recurring topics across this work include RNA regulation and disease (5 papers), Viral Infections and Immunology Research (5 papers), Cancer Genomics and Diagnostics (5 papers), Lung Cancer Treatments and Mutations (5 papers), RNA Research and Splicing (5 papers), MicroRNA in disease regulation (4 papers), Lung Cancer Research Studies (3 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Cancer Research (420 citations), Oncology (352 citations), Pulmonary and Respiratory Medicine (409 citations), Molecular Biology (627 citations) and Immunology (160 citations). Bing‐Ching Ho has collaborated with scholars based in Taiwan, United States and Australia. Frequent co-authors include Sung‐Liang Yu, Pan‐Chyr Yang, Kang‐Yi Su, Gee‐Chen Chang, Min‐Liang Kuo, Ker-Chau Li, Jin‐Yuan Shih, James Chih‐Hsin Yang, Wing‐Kai Chan and Hsuan‐Yu Chen. Their work appears in journals such as Oncotarget, PLoS ONE, Journal of Cellular Biochemistry, Scientific Reports and Cellular Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.